Abstract

Sterile alpha (SAM) and Toll/interleukin-1 receptor (TIR) motif containing 1 (SARM1) is an autoinhibitory NAD-consuming enzyme that is activated by the accumulation of nicotinamide mononucleotide (NMN) during axonal injury. Its activation mechanism is not fully understood. Here, we generate a nanobody, Nb-C6, that specifically recognizes NMN-activated SARM1. Nb-C6 stains only the activated SARM1 in cells stimulated with CZ-48, a permeant mimetic of NMN, and partially activates SARM1 in vitro and in cells. Cryo-EM of NMN/SARM1/Nb-C6 complex shows an octameric structure with ARM domains bending significantly inward and swinging out together with TIR domains. Nb-C6 binds to SAM domain of the activated SARM1 and stabilized its ARM domain. Mass spectrometry analyses indicate that the activated SARM1 in solution is highly dynamic and that the neighboring TIRs form transient dimers via the surface close to one BB loop. We show that Nb-C6 is a valuable tool for studies of SARM1 activation.

SARM1 is a key player in axon degeneration. Here, the authors generate a nanobody, which specifically recognizes the NMN-bound state of SARM1 and helps resolve the SARM1 structure in an intermediate state of activation.

Details

Title
A conformation-specific nanobody targeting the nicotinamide mononucleotide-activated state of SARM1
Author
Hou, Yun Nan 1 ; Cai, Yang 2   VIAFID ORCID Logo  ; Li, Wan Hua 3 ; He, Wei Ming 1 ; Zhao, Zhi Ying 1 ; Zhu, Wen Jie 1 ; Wang, Qiang 1 ; Mai, Xinyi 4 ; Liu, Jun 1 ; Lee, Hon Cheung 1 ; Stjepanovic, Goran 4   VIAFID ORCID Logo  ; Zhang, Hongmin 2   VIAFID ORCID Logo  ; Zhao, Yong Juan 3 

 Peking University Shenzhen Graduate School, State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Shenzhen, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319) 
 Southern University of Science and Technology, Department of Biology, School of Life Sciences, Shenzhen, China (GRID:grid.263817.9) (ISNI:0000 0004 1773 1790) 
 Peking University Shenzhen Graduate School, State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Shenzhen, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319); The Chinese University of Hong Kong, Ciechanover Institute of Precision and Regenerative Medicine, School of Medicine, Shenzhen, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482) 
 The Chinese University of Hong Kong, Kobilka Institute of Innovative Drug Discovery, School of Medicine, Shenzhen, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482) 
Pages
7898
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2756863632
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.